HealthcareServices

Global Hepatitis C Market Projected to Reach $132.21 Billion by 2029 at a CAGR of 15%

August 25, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What is the Projected CAGR for the Hepatitis C Market Size from 2025 to 2034?#_x000D_

In recent times, the size of the hepatitis C market has experienced a significant increase. It is anticipated to expand from $67.17 billion in 2024 to $75.72 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.7%. Factors contributing to the growth during this historic period include blood transfusion practices, the use of injection drugs, limited available treatments, along with the evolution of direct-acting antivirals (DaaS)._x000D_

_x000D_

The market size for hepatitis c is predicted to expand swiftly in the coming years, with projections saying it will reach$132.21 billion by 2029 with a compound annual growth rate (CAGR) of 15.0%. The projected growth within this period can be linked to efforts aimed at global eradication, enhancements in testing and screening procedures, increased expenditure on healthcare, the incorporation of telemedicine, and the emergence of innovative therapeutic combinations. Key trends to watch during the forecast period encompass affordable and accessible therapies, emphasis on intensively at-risk communities, advancements in drug formulations, cooperative initiatives and partnerships, and the incorporation of telehealth and digital technologies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Hepatitis C Market?#_x000D_

The hepatitis C market’s growth is predicted to be driven by a rise in viral infections. A viral infection is the result of a virus invading the human body. Hepatitis C treatments aim to diminish these infections by eliminating them and reestablishing the immune response in patients, post-clearance of the virus. For example, data from the US-based Centers for Disease Control and Prevention, in August 2024, revealed a surge in the percentage of individuals infected with Parvovirus B19 – a seasonal respiratory virus, across all age categories. It increased from 3% during 2022-2024 to 10% by June 2024, with the most noticeable spike among children aged 5-9 years, where it escalated from 15% during 2022-2024 to 40% in June 2024. Also, the percentage of combined samples with parvovirus B19 DNA levels saw a considerable rise from 1.5% in December 2023 to 19.9% by June 2024. Hence, this escalation in viral infections serves as a catalyst for the expansion of the hepatitis C market._x000D_

_x000D_

#How Is the Hepatitis C Market Segmented?#_x000D_

The hepatitis cmarket covered in this report is segmented – _x000D_

_x000D_

1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types_x000D_

2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments_x000D_

3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis_x000D_

4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies_x000D_

5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings_x000D_

_x000D_

Subsegments:_x000D_

1) By Chronic Hepatitis C: Genotype 1; Genotype 2; Genotype 3; Genotype 4; Genotype 5; Genotype 6 _x000D_

2) By Acute Hepatitis C: Symptomatic; Asymptomatic _x000D_

3) By Other Types: Mixed Infections; Superinfection _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Hepatitis C Market Growth?#_x000D_

North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Hepatitis C Market?#_x000D_

The increasing adoption of cutting-edge diagnostic technologies for hepatitis C treatment represents a rising trend in the hepatitis C industry. Prominent corporations in this sector are employing these state-of-the-art technologies to maintain their market positioning. For instance, in July 2022, F. Hoffmann-La Roche Ltd., a pharmaceutical and diagnostics company based in Switzerland, introduced Elecsys HCV Duo immunoassay in countries that recognise the CE Mark. By using the Elecsys HCV Duo immunoassay, the hepatitis C virus (HCV) antibody status can be examined independently and concurrently from a single human serum or plasma sample. This test can pinpoint patients showing signs of chronic infection recovery, which could evolve into other more severe conditions, such as liver cancer or other early-stage diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report_x000D_

_x000D_

#How Is the Hepatitis C Market Defined and What Are Its Core Parameters?#_x000D_

Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation, liver damage, and potentially cirrhosis or liver cancer if untreated. It spreads through contact with infected blood and is treated using antiviral medications aimed at eradicating the virus from the bloodstream. _x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_